This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cancer Research Technology Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher G. Smith and His Work in Cancer-Related Invention.
Introduction
Christopher G. Smith is an inventor based in London, United Kingdom. His patent work concerns methods for detecting cell-free DNA, including circulating tumour DNA, in samples obtained from patients.
Latest Patents
The provided information lists 1 patent associated with Smith: “Variant detection.” The invention describes a computer-implemented method that uses sequence data from patient samples to assess mutations at multiple tumour-specific loci. It calculates the mutant allele fraction and uses that result to classify whether the sample contains the target cell-free DNA. The disclosure also covers related methods and systems.
Career Highlights
Smith is associated with Cancer Research Technology Limited. His listed invention applies genomic sequencing and mutation analysis to the detection of tumour-derived DNA, an approach relevant to cancer research and patient testing.
Collaborations
The provided information identifies Katrin Heider and Charles Massie as Smith’s coworkers. Their specific roles in the patent or related work are not stated.
Conclusion
Christopher G. Smith’s listed patent focuses on detecting tumour-associated cell-free DNA through analysis of patient-specific mutations, reflecting the application of computational and genomic methods to cancer research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile